Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2021; 42(06): 554-560
DOI: 10.1055/s-0041-1740048
Original Article

Clinically Undetected Hodgkin Lymphoma Diagnosed Initially on Bone Marrow Biopsy: A Large Retrospective Observational Study from a Tertiary Care Center

Navatha Vangala
1   Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Tara Roshni Paul
1   Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Shantveer G. Uppin
1   Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Megha S. Uppin
1   Department of Pathology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
G. Sadashivudu
2   Department of Medical Oncology, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
Y. Satyanarayana Raju
3   Department of General medicine, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
,
M. Nageswara Rao
3   Department of General medicine, Nizams Institute of Medical Sciences, Hyderabad, Telangana, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Introduction Hodgkin lymphoma (HL) involving the bone marrow (BM) is relatively rare with an incidence ranging from 4% to 18%. The incidence of primary HL of marrow is 0.25%. To the best of our knowledge, the present study is the largest study on HL diagnosed initially on marrow biopsy.

Objective To establish diagnostic criteria based on clinicopathological and histological features in HL diagnosed first on the marrow.

Materials and Methods This was a retrospective study done from January 2012 to December 2020 that included 36 cases of HL diagnosed initially on BM. Based on the presence of large mononuclear or binucleate Reed–Sternberg (RS)-like cells in a polymorphous inflammatory background, HL was suspected and immunohistochemistry (IHC) with CD15 and CD30 was done. Correlation with subsequent lymph node biopsies was done, wherever possible.

Results Fever (94.4%) was the most common symptom, followed by loss of weight (66.7%). Twenty-one cases (58.4%) had uni/bicytopenia and 15 cases (41.6%) had pancytopenia. Only one case showed suspicious mononuclear RS cells on aspirates and the rest of the cases were diagnosed on trephine biopsy alone. Trephine imprints showed variable cellularity in 13 (36%) cases. Diffuse involvement was seen in 24 cases (66.7%), and focal nodular aggregates were seen in 12 cases (33.3%). Out of 36 cases, 26 cases (19 cases on marrow and 7 cases on lymph node) were confirmed as HL with IHC. Immunophenotype of the RS cells on the marrow was CD30+/CD15+ in (6/29) (20.7%) cases, CD30+/CD15− in (7/29) (24.1%) cases and CD30−/CD15+ in (6/29) (20.7%) cases. Seven cases (26.9%) were diagnosed on subsequent lymph node biopsy as mixed cellularity HL with IHC confirmation. Marrow fibrosis was seen in 16 cases (44.4%), and granulomas were seen in 8 cases (22.2%).

Conclusion In cases presenting with long-standing fever and cytopenias, HL must always be suspected, even if there are no palpable lymph nodes. Bone marrow biopsy is preferable over aspiration in such cases and IHC plays a major role in diagnosing the cases.

Keywords

Hodgkin lymphoma - primary diagnosis - bone marrow biopsy


Publication History

Article published online:
31 December 2021

© 2021. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Shi YF, Li XH, Song YQ, Song WW, Lai YM. Involvement of bone marrow in lymphoma: pathological investigation in a single-center from northern China. Int J Clin Exp Pathol 2015; 8 (06) 7102-7111
    PubMedGoogle Scholar
  • 2 Howell SJ, Grey M, Chang J. et al. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 2002; 119 (02) 408-411
    CrossrefPubMedGoogle Scholar
  • 3 Nadeem M, Naqi N, Hussain I, Khattak J, Ahmed R, Khan B. Frequency of bone marrow involvement in Hodgkin's lymphoma on first presentation. J Coll Physicians Surg Pak 2009; 19 (12) 768-771
    PubMedGoogle Scholar
  • 4 Subramanian R, Basu D, Badhe B, Dutta TK. Role of bone marrow trephine biopsy in the diagnosis of marrow involvement in Hodgkin's disease. Indian J Pathol Microbiol 2007; 50 (03) 640-643
    PubMedGoogle Scholar
  • 5 Franco V, Tripodo C, Rizzo A, Stella M, Florena AM. Bone marrow biopsy in Hodgkin's lymphoma. Eur J Haematol 2004; 73 (03) 149-155
    CrossrefPubMedGoogle Scholar
  • 6 Swerdlow SH, Campo E, Harris NL. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008
    Google Scholar
  • 7 Zhang Q-Y, Foucar K. Bone marrow involvement by hodgkin and non-hodgkin lymphomas. Hematol Oncol Clin North Am 2009; 23 (04) 873-902
    CrossrefPubMedGoogle Scholar
  • 8 Gonçalves Mde C, de Paula HM, Linardi Cda CG. et al. Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the (18)F-fluorodeoxyglucose-positron emission tomography era. Leuk Lymphoma 2015; 56 (10) 2883-2888
    CrossrefPubMedGoogle Scholar
  • 9 Gaudio F, Pedote P, Niccoli Asabella A. et al. Bone involvement in Hodgkin's lymphoma: clinical features and outcome. Acta Haematol 2018; 140 (03) 178-182
    CrossrefPubMedGoogle Scholar
  • 10 Chauhan K, Jain M, Shukla P, Grover RK. Bone marrow involvement in Hodgkin's lymphoma: data from a cancer hospital. Clin Cancer Investig J 2016; 5: 516-520
    CrossrefGoogle Scholar
  • 11 Laurent C, Arber DA, Johnston P, Fend F, Zamo A, Attygalle AD. Diagnosis of classic Hodgkin lymphoma on bone marrow biopsy. Histopathology 2020; 76 (07) 934-941
    CrossrefPubMedGoogle Scholar
  • 12 Guermazi A, Brice P, de Kerviler E. et al. Extranodal Hodgkin disease: spectrum of disease. Radiographics 2001; 21 (01) 161-179
    CrossrefPubMedGoogle Scholar
  • 13 Eustace S, O'Regan R, Graham D, Carney D. Primary multifocal skeletal Hodgkin's disease confined to bone. Skeletal Radiol 1995; 24 (01) 61-63
    CrossrefPubMedGoogle Scholar
  • 14 Fried G, Ben Arieh Y, Haim N, Dale J, Stein M. Primary Hodgkin's disease of the bone. Med Pediatr Oncol 1995; 24 (03) 204-207
    CrossrefPubMedGoogle Scholar
  • 15 Lamba B, Talreja VT, Sudeep V, Mittal S. A case report of primary Hodgkin's disease of bone marrow. Sahel Med J 2015; 18 (02) 87-88
    CrossrefGoogle Scholar
  • 16 Munker R, Harenclever D, Brosteanu O. Bone marrow involvement in Hodgkin's disease: An analysis of 135 consecutive cases. German Hodgkin's lymphoma study group. J Clin Oncol 1996; 14: 682-683
    CrossrefPubMedGoogle Scholar
  • 17 Sudalaimuthu M, Basu D. Clinicopathological features of bone marrow infiltration in Hodgkin lymphoma. Should bone marrow staging be done only in high risk patients?. Turk Patoloji Derg 2017; 33 (02) 129-133
    PubMedGoogle Scholar
  • 18 Vassilakopoulos TP, Angelopoulou MK, Constantinou N. et al. Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood 2005; 105 (05) 1875-1880
    CrossrefPubMedGoogle Scholar
  • 19 Kini JR, Suresh PK, Sinha R, Sahu KK, Kumar S, Prasad K. Value of bone marrow examination in Hodgkin lymphoma: report of three cases with review of literature. J Cancer Res Ther 2012; 8 (03) 457-459
    CrossrefPubMedGoogle Scholar
  • 20 Durosinmi MA, Mabayoje VO, Akinola NO. A review of histology of bone marrow trephine in malignant lymphomas. Niger J Med 2003; 12 (04) 198-201
    PubMedGoogle Scholar
  • 21 Ananthamurthy A, Kurien A, Ramnarayan K. The bone marrow in Hodgkin's disease–a two year study. Indian J Cancer 2000; 37 (04) 173-183
    PubMedGoogle Scholar
  • 22 Rappaport H, Berard CW, Butler JJ, Dorfman RF, Lukes RJ, Thomas LB. Report of the Committee on Histopathological Criteria Contributing to Staging of Hodgkin's Disease. Cancer Res 1971; 31 (11) 1864-1865
    PubMedGoogle Scholar
  • 23 Kar R, Dutta S, Tyagi S. Clinically unsuspected Hodgkin's lymphoma diagnosed primarily from bone marrow trephine biopsy: report of six cases. Indian J Pathol Microbiol 2008; 51 (02) 186-189
    CrossrefPubMedGoogle Scholar
  • 24 Dholaria B, Alapat D, Arnaoutakis K. Primary bone marrow Hodgkin lymphoma in an HIV-negative patient. Int J Hematol 2014; 99 (04) 503-507
    CrossrefPubMedGoogle Scholar
  • 25 Lukes RJ. Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease. Cancer Res 1971; 31 (11) 1755-1767
    PubMedGoogle Scholar
  • 26 Hall PA, D'Ardenne AJ. Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J Clin Pathol 1987; 40 (11) 1298-1304
    CrossrefPubMedGoogle Scholar
  • 27 Sah SP, Matutes E, Wotherspoon AC, Morilla R, Catovsky D. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol 2003; 56 (02) 129-132
    CrossrefPubMedGoogle Scholar
  • 28 Athanasou NA, Quinn J, Heryet A, Woods CG, McGee JO. Effect of decalcification agents on immunoreactivity of cellular antigens. J Clin Pathol 1987; 40 (08) 874-878
    CrossrefPubMedGoogle Scholar
  • 29 Horváth E, Mezei T, Pávai Z. et al. Diagnostic and differential diagnostic criteria of lymphoid neoplasms in bone marrow trephine biopsies: a study of 87 cases. Rom J Morphol Embryol 2009; 50 (03) 399-406
    PubMedGoogle Scholar
  • 30 Shah BK, Subramaniam S, Peace D, Garcia C. HIV-associated primary bone marrow Hodgkin's lymphoma: a distinct entity?. J Clin Oncol 2010; 28 (27) e459-e460
    CrossrefPubMedGoogle Scholar
  • 31 Ponzoni M, Fumagalli L, Rossi G. et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 2002; 15 (12) 1273-1278
    CrossrefPubMedGoogle Scholar
  • 32 Al-Maghrabi JA, Sawan AS, Kanaan HD. Hodgkin's lymphoma with exuberant granulomatous reaction. Saudi Med J 2006; 27 (12) 1905-1907
    PubMedGoogle Scholar
  • 33 Aggarwal P, Sharma M, Nimbran V, Kaur K. Hodgkin lymphoma with granulomas. Demystifying the dilemma. Ann Pathol Lab Med 2018; 5 (04) C72-C74
    CrossrefGoogle Scholar
  • 34 Du J, Zhang Y, Liu D, Zhu G, Zhang Q. Hodgkin's lymphoma with marked granulomatous reaction: a diagnostic pitfall. Int J Clin Exp Pathol 2019; 12 (07) 2772-2774
    PubMedGoogle Scholar
  • 35 O'Connell MJ, Schimpff SC, Kirschner RH, Abt AB, Wiernik PH. Epithelioid granulomas in Hodgkin disease. A favorable prognostic sign?. JAMA 1975; 233 (08) 886-889
    CrossrefPubMedGoogle Scholar